Meanwhile, the former head of vaccine marketing at GlaxoSmithKline of Japan was found to have been promoting the HPV vaccine after receiving commissions from the Expert Board. Following a thorough investigation we therefore request that measures are taken to address these violations in line with the Rules of Actions against the Breach of hpv vaccine danger JPMA Promotion Code.
Relationship between the HPV vaccine manufacturers and the Expert Board Since its establishment in Novemberone of the aim of the Hpv vaccine danger Board's activities has consistently been to spread and promote the HPV vaccine and inoculation in Japan, and to achieve this, it has conducted a wide range of activities targeting a variety of areas such as the government, the Diet, local municipalities, the media, medical institutions, public awareness groups and members of the public.
As a result, it has exerted a huge influence on such things as Japan's legislative process for the HPV vaccine, the government, and public opinion.
On the other hand, the Expert Board's promotional activities such as the early approval of the HPV vaccine, making the vaccine free of charge, a higher immunization rate and resuming active recommendation of the vaccine are all directly linked to increased sales of the HPV vaccine. It can therefore be assumed that, since its establishment, the Expert Board has relied on donations from HPV vaccine manufacturers to fund its activities.
It has also become apparent that a former employee who was the head of vaccine marketing at GlaxoSmithKline up until April was involved in promoting the HPV vaccine from Januaryafter receiving commissions from the Expert Board.
Hpv vaccine danger, this response is based on an insufficient investigation and is therefore unjustified. Therefore, based on this perspective, it can be said that the HPV vaccine manufacturers' huge donations to the Expert Board are a violation of the JPMA Promotion Code, as outlined below: 2 The Provision of Money to Medical Personnel This goes against the JPMA Promotion Mirena hpv cervical cancer Item 9 "Provision of cash or its equivalents" which states the following: "member companies hpv vaccine danger not offer, either directly or indirectly, any cash or its equivalents to health professionals, medical institutions, etc.
The fact that this was not clearly indicated means that it should be referred to as a hpv vaccine danger of disguised promotion that goes against the following statement in section 2. Promotion should not be disguised. Examples of such activities include the making and distribution of brochures that aim to raise public awareness or enlighten the public by emphasizing the validity and necessity of the HPV vaccine but lacking sufficient information on the danger of side effects, and tours dispatching people to meetings held abroad where participants' travel expenses are covered by the manufacturers.